News & Updates

In patients with metastatic castration-resistant prostate cancer (mCRPC) who experience disease progression while on enzalutamide treatment, continuing enzalutamide appears to improve progression-free survival (PFS), according to results of the phase IIIb PRESIDE trial.

The novel topical nonsteroidal anti-inflammatory drug (NSAID) S-flurbiprofen plaster provides relief from pain that appears similar to that achieved with diclofenac gel in patients with knee osteoarthritis, in addition to being well tolerated, according to data from an open-label, noninferiority phase III study.

About one in four cutaneous melanoma patients use at least one type of complementary and alternative medicine (CAM), of which herbs and turmeric are the most popular, reveals a prospective study from a tertiary cancer centre in Turkey.

Point-of-care (POC) diagnostic methods, such as serology or nucleic acid amplification (NAAT) tests, have high specificity and sensitivity for the coronavirus disease 2019 (COVID-19) and can be effectively deployed as border control mechanisms, according to a recent Singapore study.

Whole-exome sequencing (WES) can improve diagnosis rates in young colorectal cancer (CRC) patients who show no pathogenic variants in mismatch repair (MMR) genes or in the adenomatous polyposis coli (APC) gene, reports a recent study.